The Timing, Trajectory, and Incidence of Immune-Related Adverse Events in NSCLC Treated With Atezolizumab by Katherine E.R. Smith, MD, Stephanie L. Pritzl, MD, Wei Yu, PhD, Ilze Bara, MD, Gita Thanarajasingam, MD, Monika D. Kaul, MD, Kirstin A. Williams, PhD, CNP, Amylou C. Dueck, MD, Aaron S. Mansfield, MD

Get full text